Health Care & Life Sciences » Pharmaceuticals | Beijing Beilu Pharmaceutical Co. Ltd.

Beijing Beilu Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
246
145
268
141
225
191
Total Accounts Receivable
104
174
192
124
135
156
Inventories
57
81
82
105
109
94
Other Current Assets
9
3
5
27
1
3
Total Current Assets
416
404
548
397
471
444
Net Property, Plant & Equipment
159
197
242
257
288
336
Total Investments and Advances
23
56
58
240
311
453
Intangible Assets
16
237
186
43
53
50
Other Assets
1
4
8
1
1
1
Total Assets
621
907
1,050
956
1,141
1,289
ST Debt & Current Portion LT Debt
-
64
47
-
-
Accounts Payable
7
14
11
6
5
Income Tax Payable
6
12
5
5
4
Other Current Liabilities
16
95
15
19
40
Total Current Liabilities
29
186
78
29
49
Long-Term Debt
-
17
-
-
-
Deferred Taxes
6
6
5
17
16
Total Liabilities
29
205
81
29
49
Common Equity (Total)
559
623
891
902
1,069
Total Shareholders' Equity
559
623
891
902
1,069
Total Equity
559
666
933
902
1,069
Liabilities & Shareholders' Equity
621
907
1,050
956
1,141
Accumulated Minority Interest
-
43
41
-
-
Non-Equity Reserves
32
35
36
25
22

About Beijing Beilu Pharmaceutical Co.

View Profile
Address
7/F, Blk A, Fenglan Intl Office Bldg
Beijing Beijing 100082
China
Employees -
Website http://www.beilu.com.cn
Updated 07/08/2019
Beijing Beilu Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical product. Its products cover contrast medium product, glimepiride, and anti-anxiety product. The contrast medium product includes ferric ammonium citrate, gadopentetate, and iohexol injection.